Co-delivery of doxorubicin and P-gp inhibitor by a reduction-sensitive liposome to overcome multidrug resistance, enhance anti-tumor efficiency and reduce toxicity.
about
Targeting tumor microenvironment with PEG-based amphiphilic nanoparticles to overcome chemoresistance.Applications of nanoparticle drug delivery systems for the reversal of multidrug resistance in cancer.Preparation and therapeutic application of docetaxel-loaded poly(d,l-lactide) nanofibers in preventing breast cancer recurrence.Polysaccharide-based nanoparticles for co-loading mitoxantrone and verapamil to overcome multidrug resistance in breast tumor.Novel Dual Mitochondrial and CD44 Receptor Targeting Nanoparticles for Redox Stimuli-Triggered Release.State of the Art of Stimuli-Responsive Liposomes for Cancer Therapy.
P2860
Co-delivery of doxorubicin and P-gp inhibitor by a reduction-sensitive liposome to overcome multidrug resistance, enhance anti-tumor efficiency and reduce toxicity.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Co-delivery of doxorubicin and ...... fficiency and reduce toxicity.
@en
type
label
Co-delivery of doxorubicin and ...... fficiency and reduce toxicity.
@en
prefLabel
Co-delivery of doxorubicin and ...... fficiency and reduce toxicity.
@en
P2093
P2860
P1433
P1476
Co-delivery of doxorubicin and ...... fficiency and reduce toxicity.
@en
P2093
Qianyu Zhang
Yayuan Liu
Zhirong Zhang
P2860
P304
P356
10.3109/10717544.2014.990651
P407
P577
2014-12-10T00:00:00Z